Single domain antibodies against the collagen signalling receptor glycoprotein VI are inhibitors of collagen induced thrombus formation

Platelets

Volumn 20, Issue 4, 2009, Pages 268-276

  Walker, Adam ^a   Pugh, Nicholas ^b   Garner, Stephen F ^c   Stephens, Jonathan ^c   Maddox, Ben ^b   Ouwehand, Willem H ^c,d   Farndale, Richard W ^b   Steward, Michael ^a  

^a Domantis Limited   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Collagen; DAb; Glycoproteins; Platelets; Thrombus

Indexed keywords

ANTIBODY; ANTIBODY BLO8 1; ANTITHROMBOCYTIC AGENT; CD36 ANTIGEN; COLLAGEN BINDING PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; DRUG ACTIVITY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOGENESIS;

ANTIBODIES; BINDING SITES; BLOOD PLATELETS; COLLAGEN; EPITOPE MAPPING; EPITOPES; HUMANS; PEPTIDE LIBRARY; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; THROMBOSIS;

PLEURONECTIDAE;

EID: 67651162031     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100902893792     Document Type: Article

References (29)

1. Hulzinga E, Tsuji S, Romijn RA, Schiphorst ME, de Groot PE, Sixma JJ, Gros P. Structures of Glycoprotein Ibα and Its Complex with Von Willebrand Factor Al. Domain. Science 2002;297:1176-1179.
2. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998;94:657-666.
3. Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost 2001;86:189-97.
4. Kazunobu K, Kanaji T, Russell S, Kunicki TJ, Furihata KF, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003;102:1701-1707.
5. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999;274: 29019-29024.
6. Watson SP, Asazuma N, Atkinson B, Berlanga O, Best D, Bobe R, Jarvis G, Marshall S, Snell D, Satfford M, et al. The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen. Thromb Haemost 2001;86: 276-288.
7. Andrews RK, Suzuki-Inoue K, Shen Y, Tulasne D, Watson SP, Berndt MC. Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood 2002;99: 4219-4221.
8. Miura Y, Ohnuma M, Jung SM, Moroi M. Cloning and expression of the platelet-specific collagen receptor glycoprotein VI. Thromb Res 2000;98:301-309.
9. Jarvis GE, Raynal N, Langford JP, Onley DJ, Andrews A, Smethurst PA, Farndale RW. Identification of a major GpVI-binding locus in human type III collagen. Blood 2008;111: 4986-4996.
10. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β1-independent activation of platelets by simple collagen-like peptides: Collagen tTertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α2β1-independent platelet reactivity. Biochem J 1995;306: 337-344.
11. Smethurst PA, Joutsi-Korhonen L, O'Connor M, Wilson E, Jennings NS, Garner SF, Zhang Y, Knight CG, Dafforn TR, Buckle A, et al. Identification of the primary collagen-binding surface on human glycoprotein vi by site-directed mutagenesis and by a blocking phage antibody. Blood 2004;103:903-911.
12. Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987;69: 1712-1720.
13. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989;84: 1440-1445.
14. Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, Ohlmann P, Gachet C, Zirngibl H. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med. 2001;193:459-469.
15. Joutsi-Korhonen L, Smethurst PA, Rankin A, Gray E, Ijsseldijk M, Onley CM, Watkins NA, Williamson LM, Goodall AH, de Groot PG, et al. The low-frequency allele of the platelet collagen signalling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003;101:4372-4379.
16. Jones CI, Garner SF, Angenent W, Berzuini BC, Burns P, Farndale RW, Hogwood J, Rankin A, Stephens JC, Tom BD, et al. Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost 2007;5:1756-1765.
17. Ohlmann P, Hechler B, Ravanat C, Loyau S, Herrenschmidt N, Wanert F, Jandrot-Perrus M, Gachet C. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI fab fragment in non-human primates without modification of glycoprotein VI expression. J Thromb Haemost. 2008;6:1003-1011.
18. Takayama H, Hosaka Y, Nakayama K, Shirakawa K, Naitoh K, Matsusue T, Shinozaki M, Honda M, Yatagai Y, Kawahara T, et al. A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex. J Clin Invest 2008;118:1785-1795.
19. Stephens G, Yan Y, Jandrot-Perrus M, Villeval J, Clemetson KJ, Phillips DR. platelet activation induces metalloproteinase-dependent GPVI cleavage to down-regulate platelet reactivity to collagen. Blood 2005;105:186-191.
20. Ward ES, Güssow D, Griffiths AD, Jones PT, Winter G Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 1989; 341:544-546.
21. Jespers L, Schon O, Famm K, Winter G. Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol 2004;22:1161-1165.
22. Holt LJ, Basran A, Jones K, Chorlton J, Jespers LS, Brewis ND, Tomlinson IM. Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs. Protein Eng Des Sel 2008;21:283-288.
23. McCafferty J, Griffiths A, Winter G, Chiswell DJ. Phage antibodies: Filamentous phage displaying antibody variable domains. Nature 1990;348:552-554.
24. Siljander PR, Munnix IC, Smethurst PA, Deckmyn H, Lindhout T, Ouwehand WH, Farndale RW, Heemskerk JW. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 2004;103: 1333-1341.
25. Prakash YS, Smithson KG, Sieck GC. Application of the cavalieri principle in volume estimation using laser confocal microscopy. Neuroimage 1994;1:325-333.
26. Curtis BR, Divgi A, Garritty M, Aster RH. Delayed thrombocytopenia after treatment with abciximab: A distinct clinical entity associated with the immune response to the drug. J Thromos Haemost 2004;2:985-992.
27. Nowakowski K, Rogers J, Nelson G, Gunalingam B. Abciximab-induced thrombocytopenia: Management of bleeding in the setting of recent coronary stents. J Interven Cardiol 2008;21:100-105.
28. Katsunori H, Kahn ML, Herr AB. Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI. Blood 2006;108:936-942.
29. Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005;23: 1126-1136.